For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250617:nRSQ0772Na&default-theme=true
RNS Number : 0772N B.P. Marsh & Partners PLC 17 June 2025
17 June 2025
B.P. Marsh & Partners Plc
("B.P. Marsh", "the Company" or "the Group")
New Investment - Cameron Specialty HoldCo Limited ("Cameron Specialty")
B.P. Marsh and Partners Plc (AIM:BPM), the specialist private equity investor
in early stage financial services businesses, is pleased to announce that it
has acquired a 27% shareholding in Cameron Specialty, a London-based
underwriting agency.
B.P. Marsh has agreed to provide funding of up to £1.7m via a mix of equity
and loan facility. The loan facility was partially drawn upon completion.
Cameron Specialty, founded in 2021, specialises in UK property insurance in
the commercial combined and property owners sectors.
Cameron Specialty's Founder & CEO, Tom Kirkland, has 20 years of
experience in the insurance industry, having worked across the broking and
underwriting sectors.
With the support of B.P. Marsh, Cameron Specialty's management team will look
to expand their property insurance offering into the Republic of Ireland and
Europe, leveraging existing broker relationships, alongside developing into
other lines of business.
Tom Kirkland, Cameron Specialty CEO, commented:-
"We are excited to welcome B.P. Marsh as a partner in Cameron Specialty as we
embark on the next stage of our growth journey. Their expertise in the
insurance sector, combined with a proven track record of supporting
entrepreneurial businesses, makes them an ideal partner for us."
"With B.P. Marsh's backing, Cameron Specialty is well-positioned to deliver on
its strategic objectives of expanding our footprint across the UK and European
property insurance market and building a leading, specialist underwriting
agency. We look forward to working closely with the B.P. Marsh team to achieve
our long-term ambitions."
Adrian Colosso, Cameron Specialty Non-Executive Chairman, added:-
"We are thrilled to welcome B.P. Marsh as an investor in Cameron Specialty.
Their commitment brings not only capital but also a wealth of expertise and a
long-standing reputation in the insurance sector. This partnership marks an
exciting milestone for Cameron Specialty as we continue to grow and strengthen
our position in the market."
Dan Topping, Chief Investment Officer of the Company, who has been appointed
to the Board of Cameron Specialty, commented:-
"We are pleased to be making this investment in Cameron Specialty, a business
led by a highly experienced team. We look forward to partnering with their
management team to deliver on their growth ambitions over the coming years,
leveraging our expertise in helping early-stage underwriting agencies develop
and scale."
"Cameron Specialty represents a strong addition to our diversified portfolio
of insurance intermediaries and aligns well with the type of business we have
successfully backed and developed over the past 30 years."
For further information on B.P. Marsh, its strategy and current portfolio,
please vis-it www.bpmarsh.co.uk (http://www.bpmarsh.co.uk) or contact:
B.P. Marsh & Partners Plc www.bpmarsh.co.uk (http://www.bpmarsh.co.uk/)
Brian Marsh OBE +44 (0)20 7233 3112
Nominated Adviser & Joint Corporate Broker
Panmure Liberum Limited
Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster +44 (0)20 7886 2500
Joint Corporate Broker
Singer Capital Markets Advisory LLP
Charles Leigh Pemberton / Asha Chotai +44 (0)20 7496 3000
Financial PR & Investor Relations
Tavistock bpmarsh@tavistock.co.uk
Simon Hudson / Katie Hopkins / Kuba Stawiski +44 (0)20 7920 3150
- Ends -
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCEANKKFDNSEFA